# Safety Evaluation of LSCD101 Transplantation for Limbal Stem Cell Deficiency

> **NCT04773431** · PHASE1 · COMPLETED · sponsor: **CliPS Co., Ltd** · enrollment: 6 (actual)

## Conditions studied

- Limbus Corneae
- Limbus Corneae Insufficiency Syndrome

## Interventions

- **DRUG:** LSCD101 (Cultured Autologous Limbal Epithelial Cell Sheet) transplantation

## Key facts

- **NCT ID:** NCT04773431
- **Lead sponsor:** CliPS Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-31
- **Primary completion:** 2021-01-14
- **Final completion:** 2021-01-14
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2021-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04773431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04773431, "Safety Evaluation of LSCD101 Transplantation for Limbal Stem Cell Deficiency". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04773431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*